Cardiff Lexington (CDIX) Net Income towards Common Stockholders (2010 - 2025)
Cardiff Lexington (CDIX) reported Net Income towards Common Stockholders of -$1.4 million for Q3 2025, up 36.46% on a YoY basis from -$1.0 million in Q3 2024, and up 4.88% quarter-over-quarter from -$1.5 million in Q2 2025.
Cardiff Lexington (CDIX) Net Income towards Common Stockholders (2010 - 2025) Analysis & Trends
Cardiff Lexington has reported Net Income towards Common Stockholders for 16 years, with the latest figure at -$1.4 million in Q3 2025.
- For the quarter ending Q3 2025, Net Income towards Common Stockholders rose 36.46% year-over-year to -$1.4 million; the trailing twelve-month figure through Dec 2025 stood at -$3.6 million (up 15.95% YoY), and the FY2024 full-year result was -$4.3 million, down 289.7% from the prior year.
- Net Income towards Common Stockholders for Q3 2025 stood at -$1.4 million, up from -$1.5 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $1.8 million in Q3 2023, with the low at -$3.9 million in Q4 2022.
- Historically, Net Income towards Common Stockholders has averaged -$726062.4 across 5 years, with a median of -$457759.0 in 2024.
- Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders jumped 1216.58% — and 2024, when it slumped 1704.38%.
- Cardiff Lexington's Net Income towards Common Stockholders stood at -$888595.0 in 2021, then plunged by 341.67% to -$3.9 million in 2022, then soared by 101.84% to $72096.0 in 2023, then tumbled by 1704.38% to -$1.2 million in 2024, then dropped by 21.73% to -$1.4 million in 2025.
- The last three Net Income towards Common Stockholders figures came in at -$1.4 million (Q3 2025), -$1.5 million (Q2 2025), and -$696222.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | 1.86 Bn |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 702.00 Mn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 275.04 Mn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 15.90 Mn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 96.31 Mn |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 348.68 Mn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 68.68 Mn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 66.30 Mn |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 80.67 Mn |
| 10 | Cardiff Lexington | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.41 Mn |
| Jun 30, 2025 | -1.48 Mn |
| Mar 31, 2025 | -696,222.00 |
| Dec 31, 2024 | -1.16 Mn |
| Sep 30, 2024 | -2.22 Mn |
| Jun 30, 2024 | -457,759.00 |
| Mar 31, 2024 | -434,738.00 |
| Dec 31, 2023 | 72,096.00 |
| Sep 30, 2023 | 1.83 Mn |
| Jun 30, 2023 | 690,334.00 |
| Mar 31, 2023 | -360,938.00 |
| Dec 31, 2022 | -3.92 Mn |
| Sep 30, 2022 | -264,774.00 |
| Jun 30, 2022 | -61,826.00 |
| Mar 31, 2022 | -1.56 Mn |
| Dec 31, 2021 | -888,595.00 |
| Sep 30, 2021 | 328,718.00 |
| Jun 30, 2021 | -34,745.00 |
| Mar 31, 2021 | -1.77 Mn |
| Dec 31, 2020 | -1.78 Mn |